| Literature DB >> 31599199 |
Gabriel Ștefan1, Cosmin Florescu2, Alexandru-Anton Sabo3, Simona Stancu1, Gabriel Mircescu1.
Abstract
Background: We aimed to evaluate the relationship between biopsy-proven kidney lesions, subclinical markers of atherosclerosis and intrarenal resistive index (RRI) in chronic kidney disease (CKD) patients.Entities:
Keywords: Intrarenal resistive index; kidney biopsy; renal arteriolosclerosis; systemic atherosclerosis
Mesh:
Year: 2019 PMID: 31599199 PMCID: PMC6807913 DOI: 10.1080/0886022X.2019.1674159
Source DB: PubMed Journal: Ren Fail ISSN: 0886-022X Impact factor: 2.606
Histological variables.
| Global glomerulosclerosis | Percentage of glomeruli with global glomerulosclerosis |
| Segmental glomerulosclerosis | Percentage of glomeruli with segmental glomerulosclerosis |
| Mesangial hypercellularity | Percentage of glomeruli with mesangial hypercellularity |
| Endocapillary hypercellularity | Percentage of glomeruli with endocapillary hypercellularity |
| Extracapillary hypercellularity | Percentage of glomeruli with extracapillary hypercellularity |
| Podocyte effacement | Presence of foot process effacement in EM (+/−) |
| Endothelial swelling | Presence of endothelial cell swelling in EM (+/−) |
| GBM thickness | Thickness of the GBM in EM (nm) |
| Interstitial fibrosis/tubular atrophy | Modfied Kliem classification: 0, absent; 0.5, focal area; 1, <10%; 2, 10–25%; 3, 25–50%; 4, >50% |
absence of arteriosclerosis: normal intima thickness; moderate arteriosclerosis: thickening of intima with an intima/media ratio <1; severe arteriosclerosis: thickening of intima with an intima/media ratio ≥1. | |
| Fibrinoid necrosis | Disruption of the GBM with fibrin exudation |
EM: electron microscopy; GBM: glomerular basement membrane.
Patient characteristics.
| All | RRI > 0.7 | RRI ≤ 0.7 | ||
|---|---|---|---|---|
| Age (years) | 54.1 (49.7–58.6) | 62.1 (57.4–66.7) | 49.1 (43.0–55.3) | <0.001 |
| Male gender (%) | 57 | 65 | 52 | 0.4 |
| Primary renal disease (%) | 0.03 | |||
| Glomerular nephropathy | 75 | 53 | 89 | |
| Diabetic nephropathy | 14 | 24 | 7 | |
| Vascular nephropathy | 7 | 18 | 0 | |
| Tubulo-interstitial nephropathy | 5 | 6 | 4 | |
| Hypertension (%) | 73 | 82 | 67 | 0.2 |
| MAP (mmHg) | 161.0 (151.7–170.4) | 172.9 (156.2–189.7) | 154.0 (143.0–165.0) | 0.04 |
| Diabetes mellitus (%) | 20 | 35 | 11 | 0.05 |
| Atherosclerosis score | 1 (0–1) | 1 (1–2) | 0 (0–1) | <0.001 |
| Hemoglobin (g/dL) | 11.50 (10.70–12.30) | 10.54 (9.16–11.93) | 12.07 (11.09–13.04) | 0.06 |
| Serum albumin (g/dL) | 3.34 (3.11–3.57) | 3.46 (3.11–3.81) | 3.28 (2.96–3.59) | 0.4 |
| Cholesterol (mg/dL) | 218.0 (195.0–251.0) | 200.0 (145.0–243.0) | 237.0 (200.0–300.0) | 0.07 |
| Triglycerides (mg/dL) | 195.9 (165.9–225.8) | 174.0 (131.8–216.2) | 208.8 (166.9–250.7) | 0.2 |
| Uric acid (mg/dL) | 7.76 (6.98–8.54) | 8.41 (6.84–9.97) | 7.38 (6.49–8.26) | 0.7 |
| C reactive protein (mg/dL) | 6 (3–15) | 9.5 (2–24) | 4 (1–15) | 0.3 |
| ESR (mm/h) | 43.5 (22.0–77.0) | 76.0 (22.0–97.0) | 35.0 (17.0–72.0) | 0.2 |
| eGFR (mL/min) | 28.10 (15.06–47.76) | 20.10 (13.60–47.76) | 39.00 (15.05–72.80) | 0.1 |
| CKD class (%) | 0.2 | |||
| G1 | 12 | 0 | 19 | |
| G2 | 14 | 13 | 15 | |
| G3 | 23 | 19 | 26 | |
| G4 | 21 | 31 | 15 | |
| G5 | 30 | 38 | 26 | |
| UPCR (g/g) | 3.32 (1.60–4.84) | 2.69 (0.66–4.84) | 3.68 (1.10–5.98) | 0.4 |
| UACR (g/g) | 1.99 (0.87–3.24) | 1.94 (0.53–3.81) | 2.11 (0.63–4.01) | 0.6 |
| Hematuria (mm3) | 45 (20–160) | 70 (15–230) | 30 (8–180) | 0.4 |
| Abdominal aortic calcification score | 0 (0–3) | 3 (0–6) | 0 (0–1) | 0.02 |
| Intima media thickness (mm) | 0.06 (0.06–0.07) | 0.07 (0.06–0.08) | 0.06 (0.06–0.08) | 0.06 |
| Renal morphometry | ||||
| Glomerulosclerosis global or focal (%) | 68 | 82 | 59 | 0.1 |
| Global glomerulosclerosis (%)*† | 19.0 (12.7–25.4) | 25.2 (14.3–36.1) | 15.1 (7.1–23.2) | 0.05 |
| Focal glomerulosclerosis (%)*† | 13.9 (6.7–21.0) | 18.2 (4.8–31.7) | 11.1 (2.5–19.8) | 0.2 |
| Endocapillary proliferation (%) | 27 | 24 | 30 | 0.6 |
| Extracapillary proliferation (%) | 25 | 18 | 30 | 0.3 |
| Arteriolosclerosis (%) | 66 | 88 | 52 | 0.01 |
| Severe arteriosclerosis (%) | 14 | 24 | 7 | 0.1 |
| Fibrinoid necrosis (%) | 11 | 6 | 15 | 0.3 |
| Interstitial fibrosis/Tubular atrophy*‡ | 1 (0.5–2) | 2 (1–3) | 1 (0.5–2) | 0.03 |
| GBM thickness (nm) | 420.0 (380.0–500.0) | 475.0 (350.0–713.9) | 400.0 (370.1–470.0) | 0.05 |
| Podocyte effacement (%) | 71 | 56 | 80 | 0.1 |
| Endothelial swelling (%) | 59 | 75 | 48 | 0.08 |
*median.
**hypertensive nephropathy, atheroembolic renal disease.
†percentage of the total number of examined glomeruli.
‡Kliem classification modified: 0 absent; 0.5 focal area; 1 < 10%; 2 10–25%; 3 25–50%; 4 > 50%.
CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate (CKD-EPI); ESR: erythrocyte sedimentation rate; GBM: glomerular basement membrane; MAP: mean arterial blood pressure; UAlb/Cr: urinary albumin to creatinine ratio; UP/Cr: urinary protein to creatinine ratio; RRI: renal resistive index.
Figure 1.Renal resistive index (RRI) increased with chronic kidney disease (CKD) stages (G).
Figure 2.Patients with glomerulosclerosis (global and segmental), arteriolosclerosis, severe arteriosclerosis and endothelial swelling had higher renal resistive index.
Correlation coefficients between RRI and investigated parameters.
| Correlation coefficient | ||
|---|---|---|
| Clinical parameters | ||
| Age (years) | 0.55 | <0.001 |
| MAP (mmHg) | 0.18 | 0.2 |
| Kidney disease parameters | ||
| eGFR (mL/min) | −0.34 | 0.02 |
| UAlb/Cr (g/g) | −0.08 | 0.5 |
| UP/Cr (g/g) | −0.14 | 0.3 |
| Hematuria (mm3) | 0.14 | 0.3 |
| Systemic atherosclerosis parameters | ||
| Atherosclerosis score | 0.50 | 0.001 |
| AAC score | 0.50 | <0.01 |
| IMT (mm) | 0.34 | 0.02 |
| Histopathologic parameters | ||
| Global glomerulosclerosis (%) | 0.31 | 0.03 |
| Segmental glomerulosclerosis (%) | 0.16 | 0.3 |
| GBM thickness (nm) | 0.22 | 0.1 |
| Interstitial fibrosis/Tubular atrophy | 0.35 | 0.01 |
| Arteriosclerosis | 0.18 | 0.2 |
*Pearson or Spearman according to distribution.
†percentage of the total number of examined glomeruli.
‡Kliem classification modified: 0 absent; 0.5 focal area; 1 < 10%; 2 10–25%; 3 25–50%; 4 > 50%.
§Arteriosclerosis score: 1, absent; 2, moderate; 3, severe.
AAC score: abdominal aortic calcification score; eGFR: estimated glomerular filtration rate (CKD-EPI); GBM: glomerular basement membrane; IMT: intima media thickness; MAP: mean arterial blood pressure; UAlb/Cr: urinary albumin to creatinine ratio; UP/Cr: urinary protein to creatinine ratio.
Relationship between intrarenal resistivity index >0.7 and the studied atherosclerotic markers and histopathologic lesions in five separate models of multivariable adjusted binary logistic regression analysis.
| Model | Variable | Exp( | ||
|---|---|---|---|---|
| AAC score | Age | 0.13 | 1.14 (1.03–1.25) | <0.001 |
| UAlb/Cr | −0.32 | 0.72 (0.50–1.02) | 0.06 | |
| Constant | −6.88 | 0.001 | <0.01 | |
| IMT | Age | 0.08 | 1.09 (1.01–1.16) | 0.01 |
| Diabetes mellitus | 2.13 | 8.42 (1.19–59.47) | 0.03 | |
| eGFR | −0.02 | 0.97 (0.94–1.00) | 0.05 | |
| Constant | −4.76 | 0.009 | 0.02 | |
| Arteriolosclerosis | Age | 0.07 | 1.07 (1.00–1.15) | 0.03 |
| Diabetes mellitus | 2.58 | 13.19 (1.24–139.95) | 0.03 | |
| Arteriolosclerosis | 2.42 | 11.28 (1.02–124.86) | 0.04 | |
| Constant | −7.07 | 0.001 | <0.01 | |
| Global glomerulosclerosis | Age | 0.08 | 1.09 (1.01–1.17) | 0.01 |
| Diabetes mellitus | 2.16 | 8.74 (1.23–61.74) | 0.03 | |
| eGFR | −0.03 | 0.97 (0.94–1.00) | 0.05 | |
| Constant | −4.88 | 0.008 | 0.01 | |
| Interstitial fibrosis/tubular atrophy | Age | 0.08 | 1.09 (1.01–1.17) | 0.01 |
| Diabetes mellitus | 2.16 | 8.74 (1.23–61.74) | 0.03 | |
| eGFR | −0.03 | 0.97 (0.94–1.00) | 0.05 | |
| Constant | −4.88 | 0.008 | 0.01 |
Variables entered at step 1 for each model: age, diabetes mellitus, arterial hypertension, eGFR, UAlb/Cr and AAC score or IMT or arteriolosclerosis or global glomerulosclerosis or interstitial fibrosis/tubular atrophy - depending on the model.
*Cox and Snell R2 = 0.37; Nagelkerke R2 = 0.50; (χ2=14.82; dif = 2; p = 0.001).
**Cox and Snell R2 = 0.34; Nagelkerke R2 = 0.46; (χ2 = 17.30; dif = 3; p = 0.001).
†Cox and Snell R2 = 0.36; Nagelkerke R2 = 0.49; (χ2 = 19.09; dif = 3; p < 0.001).
‡Cox and Snell R2 = 0.35; Nagelkerke R2 = 0.47; (χ2 = 18.11; dif = 3; p < 0.001).
§Cox and Snell R2 = 0.35; Nagelkerke R2 = 0.47; (χ2 = 18.11; dif = 3; p < 0.001).